$MTEM
Molecular Templates, Inc.

2013 Form 10-K Financial Statement

#000119312514085581 Filed on March 06, 2014

View on sec.gov

Income Statement

Concept 2013 2012 Q4 2012 Q3
Revenue $0.00 $2.020M $1.800M
YoY Change 3266.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.190M $1.850M $1.740M
YoY Change 29.8% 30.28% 32.82%
% of Gross Profit
Research & Development $29.33M $6.160M $4.039M
YoY Change 56.15% -8.61% -37.68%
% of Gross Profit
Depreciation & Amortization $300.0K $340.0K $340.0K
YoY Change 50.0% 161.54% 112.5%
% of Gross Profit
Operating Expenses $38.52M $8.010M $5.780M
YoY Change 48.92% -1.84% -25.79%
Operating Profit -$26.02M -$3.983M
YoY Change 30.13% -48.86%
Interest Expense $136.0K $30.00K $25.00K
YoY Change 70.0% 200.0% 150.0%
% of Operating Profit
Other Income/Expense, Net -$2.325M $34.36M $2.970M
YoY Change -95.46% 1118.44% -18.85%
Pretax Income -$28.21M $28.39M -$991.0K
YoY Change -60.34% -637.69% -76.0%
Income Tax $202.0K $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$28.42M $28.39M -$991.0K
YoY Change -60.05% -638.16% -75.98%
Net Earnings / Revenue 1405.35% -55.06%
Basic Earnings Per Share -$0.49 $0.50 -$0.02
Diluted Earnings Per Share -$0.49 -$0.10 -$0.06
COMMON SHARES
Basic Shares Outstanding 57.83M 56.25M shares 55.65M shares
Diluted Shares Outstanding 57.83M 64.41M shares

Balance Sheet

Concept 2013 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.70M $70.80M $65.80M
YoY Change -7.2% 248.77% 160.08%
Cash & Equivalents $7.300M $11.03M $8.634M
Short-Term Investments $58.40M $59.80M $57.20M
Other Short-Term Assets $2.200M $1.200M $1.100M
YoY Change 83.33% 300.0% 37.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $86.00M $87.65M $84.43M
YoY Change -1.94% 326.65% 223.49%
LONG-TERM ASSETS
Property, Plant & Equipment $700.0K $812.0K $728.0K
YoY Change -12.5% 49.54% 82.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $16.40M
YoY Change
Other Assets $1.100M $1.059M $1.059M
YoY Change 0.0% -21.5% 253.0%
Total Long-Term Assets $18.10M $1.871M $1.787M
YoY Change 905.56% -1.11% 123.38%
TOTAL ASSETS
Total Short-Term Assets $86.00M $87.65M $84.43M
Total Long-Term Assets $18.10M $1.871M $1.787M
Total Assets $104.1M $89.52M $86.22M
YoY Change 16.31% 299.01% 220.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.700M $908.0K $739.0K
YoY Change 88.89% -61.99% 146.33%
Accrued Expenses $10.60M $2.257M $1.817M
YoY Change 32.5% 29.94% -64.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.00M $17.45M $16.19M
YoY Change 54.29% 103.13% 199.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.6M $85.90M $114.1M
YoY Change 17.11% 813.83% 850.83%
Total Long-Term Liabilities $100.6M $85.90M $114.1M
YoY Change 17.11% 813.83% 850.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.00M $17.45M $16.19M
Total Long-Term Liabilities $100.6M $85.90M $114.1M
Total Liabilities $127.6M $103.4M $130.3M
YoY Change 23.4% 475.8% 648.86%
SHAREHOLDERS EQUITY
Retained Earnings -$323.3M -$351.7M
YoY Change 28.21%
Common Stock $309.4M $307.6M
YoY Change 20.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$23.50M -$13.85M -$44.08M
YoY Change
Total Liabilities & Shareholders Equity $104.1M $89.52M $86.22M
YoY Change 16.31% 299.01% 220.51%

Cashflow Statement

Concept 2013 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income -$28.42M $28.39M -$991.0K
YoY Change -60.05% -638.16% -75.98%
Depreciation, Depletion And Amortization $300.0K $340.0K $340.0K
YoY Change 50.0% 161.54% 112.5%
Cash From Operating Activities $10.15M $4.980M -$2.250M
YoY Change -66.06% -205.06% -64.51%
INVESTING ACTIVITIES
Capital Expenditures $158.0K -$150.0K -$100.0K
YoY Change -67.22% -28.57% -68.75%
Acquisitions
YoY Change
Other Investing Activities -$16.14M -$2.900M $790.0K
YoY Change -65.06% -160.92% -50.0%
Cash From Investing Activities -$16.29M -$3.060M $680.0K
YoY Change -65.09% -167.25% -46.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.392M
YoY Change -89.08%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.392M 460.0K 1.900M
YoY Change -89.08% 245.45%
NET CHANGE
Cash From Operating Activities 10.15M 4.980M -2.250M
Cash From Investing Activities -16.29M -3.060M 680.0K
Cash From Financing Activities 2.392M 460.0K 1.900M
Net Change In Cash -3.750M 2.380M 330.0K
YoY Change -172.86% -1352.63% -107.28%
FREE CASH FLOW
Cash From Operating Activities $10.15M $4.980M -$2.250M
Capital Expenditures $158.0K -$150.0K -$100.0K
Free Cash Flow $9.993M $5.130M -$2.150M
YoY Change -66.05% -213.25% -64.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59345804 shares
CY2010Q4 thld Aggregate Offering Price Of Common Stock
AggregateOfferingPriceOfCommonStock
15000000
CY2013Q2 dei Entity Public Float
EntityPublicFloat
263301745
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.36
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2745718 shares
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
765848 shares
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
4943000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3672179 shares
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8691000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.45
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1077784 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
59819000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
87650000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1740000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5750000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
908000
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
122000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
51564000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
59808000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17451000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-13853000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
309343000
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
4483000
CY2012Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2037000
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
32558000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-323263000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8536000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
268000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
56000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89521000
CY2012Q4 us-gaap Liabilities
Liabilities
103374000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
53097000
CY2011Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
9209000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5882000
CY2011Q4 thld Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOutstandingNumber
1196500 shares
CY2012Q1 thld Aggregate Offering Price Of Common Stock
AggregateOfferingPriceOfCommonStock
15000000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56431207 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56431207 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
1.18
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.18
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5098972 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
498411 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2257000
CY2012Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2115000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1059000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
44769000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
51564000
CY2012Q4 us-gaap Assets
Assets
89521000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11029000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2552000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3513000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
59819000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1167000
CY2012Q4 us-gaap Other Receivables
OtherReceivables
15635000
CY2012Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
70825000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
958000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
812000
CY2012Q4 thld Other Accrued Expenses
OtherAccruedExpenses
98000
CY2012Q4 thld Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOutstandingNumber
1844000 shares
CY2012Q4 thld Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
209000
CY2012Q4 thld Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
7000
CY2012Q4 thld Available For Sale Debt Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleDebtSecuritiesGrossUnrealizedGainAccumulatedInInvestments
18000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59232611 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59232611 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
1.69
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.66
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6526506 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
175236 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.65
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8300000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6483107 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3161000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
918000
CY2013Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2023000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7444000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2937000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1689000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
150000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
238000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
63141000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27016000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
28000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-23475000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
328116000
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2682000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
23421000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351678000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
14722000
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
240000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
59000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104118000
CY2013Q4 us-gaap Liabilities
Liabilities
127593000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
953000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
76916000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
828000
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
58390000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
86009000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
74726000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3327000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1059000
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
16364000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
31988000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
63141000
CY2013Q4 us-gaap Assets
Assets
104118000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
10500000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7279000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2709000
CY2013Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
14817000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5427000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8600000
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
21151000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
74754000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2246000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10500000
CY2013Q4 us-gaap Other Receivables
OtherReceivables
18094000
CY2013Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
82033000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1069000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
686000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
781000
CY2013Q4 thld Share Based Compensation Arrangement Number Of Shares Authorized As Percentage Of Common Stock Outstanding
ShareBasedCompensationArrangementNumberOfSharesAuthorizedAsPercentageOfCommonStockOutstanding
0.05 pure
CY2013Q4 thld Other Accrued Expenses
OtherAccruedExpenses
329000
CY2013Q4 thld Share Based Compensation Arrangement By Share Based Payment Award Increase In Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorized
1250000 shares
CY2013Q4 thld Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOutstandingNumber
1663500 shares
CY2013Q4 thld Net Operating Loss Deferred Tax Asset From Excess Benefits From Stock Option Exercises
NetOperatingLossDeferredTaxAssetFromExcessBenefitsFromStockOptionExercises
400000
CY2013Q4 thld Aggregate Offering Price Of Common Stock
AggregateOfferingPriceOfCommonStock
2700000
CY2013Q4 thld Plan Participants Withheld To Purchase Stock
PlanParticipantsWithheldToPurchaseStock
300000
CY2013Q4 thld Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
179000
CY2013Q4 thld Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments
10000
CY2013Q4 thld Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
10000
CY2013Q4 thld Available For Sale Debt Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleDebtSecuritiesGrossUnrealizedGainAccumulatedInInvestments
38000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1250000 shares
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45900000 shares
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.38
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.64
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23851000
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.24
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1196500 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45900000 shares
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11603 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
258436 shares
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
369000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25655000
CY2011 us-gaap Contracts Revenue
ContractsRevenue
62000
CY2011 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
95000
CY2011 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
17000
CY2011 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
28154000
CY2011 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
25000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-30036000
CY2011 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4358000
CY2011 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-2000
CY2011 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
4358000
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11600000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25653000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-25653000
CY2011 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
885000
CY2011 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
149000
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
24007000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
528000
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2011 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2026000
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
100000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5710000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30224000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
1039000
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
525000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2809000
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
17463000
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
223000
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
CY2011 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2037000
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
914000
CY2011 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1995000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2137000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30224000
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8722000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9182000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24388000
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-1482000
CY2011 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1039000
CY2011 us-gaap Income Tax Expense Benefit Extraordinary Items
IncomeTaxExpenseBenefitExtraordinaryItems
0
CY2011 us-gaap Operating Expenses
OperatingExpenses
30098000
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
25000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011 thld Income Tax Reconciliation Tax Assets Not Benefited
IncomeTaxReconciliationTaxAssetsNotBenefited
1105000
CY2011 thld Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExercised
shares
CY2011 thld Income Tax Reconciliation Unutilized Utilized Net Operating Losses
IncomeTaxReconciliationUnutilizedUtilizedNetOperatingLosses
11731000
CY2011 thld Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Cancelled And Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledAndExpired
258436 shares
CY2011 thld Issuance Of Common Stock Issuance Cost
IssuanceOfCommonStockIssuanceCost
2500000
CY2013 dei Trading Symbol
TradingSymbol
THLD
CY2013 dei Entity Registrant Name
EntityRegistrantName
THRESHOLD PHARMACEUTICALS INC
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001183765
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1250000 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y6M18D
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57832000 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.49
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.10
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
167245 shares
CY2013 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10151000
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.56
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1663500 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57832000 shares
CY2013 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.85 pure
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
145641 shares
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <b><i>Concentration of Credit Risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Financial instruments which potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents and marketable securities. The Company invests in a variety of financial instruments, such as, but not limited to, certificates of deposit, corporate and municipal bonds, United States Treasury and agency securities. The Company is exposed to credit risk in the event of default by the financial institutions for amounts in excess of Federal Deposit Insurance Corporation insured limits. The Company performs periodic evaluations of the relative credit standings of these financial institutions, and by policy, limits the amount of credit exposure with any one financial institution or commercial issuer.</p> </div>
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1079000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2392000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
90325 shares
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates, assumptions and judgments made by management include those related to the valuation of equity and related instruments, revenue recognition, stock-based compensation and clinical trial accrued liabilities.</p> </div>
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28398000
CY2013 us-gaap Contracts Revenue
ContractsRevenue
12495000
CY2013 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
136000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-26024000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9592000
CY2013 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
28000
CY2013 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
5000
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
101968000
CY2013 us-gaap Licenses Revenue
LicensesRevenue
0
CY2013 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2325000
CY2013 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
17000
CY2013 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-2325000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11600000
CY2013 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
2600000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-28213000
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2459000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-28415000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1416000
CY2013 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
510000
CY2013 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
11462000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
158000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000
CY2013 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1694000
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
100000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9185000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2392000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
30005000
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1900000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
4922000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1506000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3750000
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
80495000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
486000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16293000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
202000
CY2013 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
12500000
CY2013 us-gaap Income Tax Expense Benefit Extraordinary Items
IncomeTaxExpenseBenefitExtraordinaryItems
0
CY2013 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2013 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
5338000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29334000
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
904000
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1794000
CY2013 thld Income Tax Reconciliation Tax Assets Not Benefited
IncomeTaxReconciliationTaxAssetsNotBenefited
1926000
CY2013 thld Exercise Of Warrants Liability Measured At Fair Value
ExerciseOfWarrantsLiabilityMeasuredAtFairValue
11462000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
300000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4922000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
790000
CY2013 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
CY2013 us-gaap Operating Expenses
OperatingExpenses
38519000
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
55000
CY2013 thld Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExercised
shares
CY2013 thld Share Based Compensation Arrangement By Share Based Payment Award Offering Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
P24M
CY2013 thld Reclassifications Of Fair Value From Liability To Permanent Equity
ReclassificationsOfFairValueFromLiabilityToPermanentEquity
11500000
CY2013 thld Exercise Of Warrants To Purchase Value Of Class Common Stock
ExerciseOfWarrantsToPurchaseValueOfClassCommonStock
1882000
CY2013 thld Unrecognized Tax Benefits Increases Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromCurrentPeriodTaxPositions
CY2013 thld Employee Stock Purchase Plan Purchase Period
EmployeeStockPurchasePlanPurchasePeriod
P6M
CY2013 thld Reimbursement Expenses
ReimbursementExpenses
16500000
CY2013 thld Income Tax Reconciliation Unutilized Utilized Net Operating Losses
IncomeTaxReconciliationUnutilizedUtilizedNetOperatingLosses
9747000
CY2013 thld Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Cancelled And Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledAndExpired
90325 shares
CY2013 thld Unrecognized Tax Benefits Increases Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreaseResultingFromPriorPeriodTaxPositions
CY2013 thld Stock Available For Issuance During Period Shares Employee Stock Purchase Plans
StockAvailableForIssuanceDuringPeriodSharesEmployeeStockPurchasePlans
235896 shares
CY2013 thld Weighted Average Maturity For Available For Sale Securities
WeightedAverageMaturityForAvailableForSaleSecurities
P6M12D
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1250000 shares
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54219000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.25
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.24
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
150677 shares
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29913000
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.39
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1844000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54219000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
402580 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
14627 shares
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
623000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71123000
CY2012 us-gaap Contracts Revenue
ContractsRevenue
5867000
CY2012 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-115000
CY2012 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2012 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
93745000
CY2012 us-gaap Licenses Revenue
LicensesRevenue
0
CY2012 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
80000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-19999000
CY2012 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-51216000
CY2012 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
12000
CY2012 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-51216000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7800000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-71135000
CY2012 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
15635000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-71135000
CY2012 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
738000
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12323000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
482000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000
CY2012 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1285000
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
200000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7080000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21910000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
61633000
CY2012 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
8800000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1700000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
3010000
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1008000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5147000
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
33285000
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
288000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
CY2012 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
14266000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
520000
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1160000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1481000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21910000
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-24186000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46676000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18786000
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
17414000
CY2012 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
600000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3010000
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
5900000
CY2012 us-gaap Income Tax Expense Benefit Extraordinary Items
IncomeTaxExpenseBenefitExtraordinaryItems
0
CY2012 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2012 us-gaap Operating Expenses
OperatingExpenses
25866000
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
46000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012 thld Income Tax Reconciliation Tax Assets Not Benefited
IncomeTaxReconciliationTaxAssetsNotBenefited
143000
CY2012 thld Exercise Of Warrants Liability Measured At Fair Value
ExerciseOfWarrantsLiabilityMeasuredAtFairValue
27867000
CY2012 thld Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExercised
shares
CY2012 thld Reclassifications Of Fair Value From Liability To Permanent Equity
ReclassificationsOfFairValueFromLiabilityToPermanentEquity
27900000
CY2012 thld Exercise Of Warrants To Purchase Value Of Class Common Stock
ExerciseOfWarrantsToPurchaseValueOfClassCommonStock
8849000
CY2012 thld Unrecognized Tax Benefits Increases Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromCurrentPeriodTaxPositions
CY2012 thld Reimbursement Expenses
ReimbursementExpenses
13100000
CY2012 thld Income Tax Reconciliation Unutilized Utilized Net Operating Losses
IncomeTaxReconciliationUnutilizedUtilizedNetOperatingLosses
7455000
CY2012 thld Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Cancelled And Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledAndExpired
14627 shares
CY2012 thld Reclassification Of Fair Value Of Warrants Exercised
ReclassificationOfFairValueOfWarrantsExercised
27867000
CY2012 thld Unrecognized Tax Benefits Increases Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreaseResultingFromPriorPeriodTaxPositions
CY2012 thld Issuance Of Common Stock Issuance Cost
IssuanceOfCommonStockIssuanceCost
400000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2013Q1 us-gaap Contracts Revenue
ContractsRevenue
2922000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-9214000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.30
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.30
CY2012Q1 us-gaap Contracts Revenue
ContractsRevenue
252000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-115533000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2012Q2 us-gaap Contracts Revenue
ContractsRevenue
1797000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
17001000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2013Q2 us-gaap Contracts Revenue
ContractsRevenue
3180000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-12788000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2012Q3 us-gaap Contracts Revenue
ContractsRevenue
1797000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-991000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2013Q3 us-gaap Contracts Revenue
ContractsRevenue
3181000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
1176000
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2012Q4 us-gaap Contracts Revenue
ContractsRevenue
2021000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
28388000
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2013Q4 us-gaap Contracts Revenue
ContractsRevenue
3212000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-7589000

Files In Submission

Name View Source Status
0001193125-14-085581-index-headers.html Edgar Link pending
0001193125-14-085581-index.html Edgar Link pending
0001193125-14-085581.txt Edgar Link pending
0001193125-14-085581-xbrl.zip Edgar Link pending
d652716d10k.htm Edgar Link pending
d652716dex1011.htm Edgar Link pending
d652716dex231.htm Edgar Link pending
d652716dex31.htm Edgar Link pending
d652716dex311.htm Edgar Link pending
d652716dex312.htm Edgar Link pending
d652716dex321.htm Edgar Link pending
d652716dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g652716g12n40.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thld-20131231.xml Edgar Link completed
thld-20131231.xsd Edgar Link pending
thld-20131231_cal.xml Edgar Link unprocessable
thld-20131231_def.xml Edgar Link unprocessable
thld-20131231_lab.xml Edgar Link unprocessable
thld-20131231_pre.xml Edgar Link unprocessable